Results 161 to 170 of about 163,352 (307)

Is Saturation Biopsy Still a Viable Alternative to Fusion Biopsy in the Era of Multiparametric MRI? A Comparative Analysis in Patients With Prior Negative Biopsy

The Prostate, EarlyView.
ABSTRACT Background We aimed to compare the diagnostic accuracy of transrectal ultrasound (TRUS)‐guided saturation biopsy (SB) and multiparametric MRI (mpMRI)‐TRUS fusion‐guided combined biopsy (CB) in patients with prior negative prostate biopsies. Methods We retrospectively analyzed data from 160 patients who underwent transrectal prostate biopsy ...
Arda Taşkın Taşkıran, Yusuf Şenoğlu   +1 more
wiley   +1 more source

Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2-3 cancer. [PDF]

BJUI Compass
Teramoto Y, Wang Y, Miyamoto H.
europepmc   +1 more source

Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis [PDF]

, 2018
Badiyan, Shahed, Gay, Hiram A, Markovina, Stephanie, Meeks, Marshall W, Michalski, Jeff, Paradis, Alethea, Sandhu, Gurdarshan, Vetter, Joel   +7 more
core   +2 more sources

A Zosteriform Papular Cutaneous Eruption

JEADV Clinical Practice, EarlyView.
Silvia Borriello, Umberto Santaniello, Astrid Lappi, Paolo Borrelli, Angelo Battaglia, Roberta Patetta, Sophie Frassy, Simone Ribero, Pietro Quaglino   +8 more
wiley   +1 more source

Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate Cancer

The Prostate, EarlyView.
ABSTRACT Background The management of intermediate‐risk early prostate cancer (PCa) is challenging due to the difficulty in distinguishing indolent from aggressive tumors. This study explores the association between genomic alterations and the tumor and its microenvironment (TME) and implications for disease progression. Methods We performed multi‐omic
William Lautert‐Dutra, Camila M. Melo, Luiz P. Chaves, Francisco C. Souza, Vida Talebian, Cheryl Crozier, Mary Anne Quintayo, Linda Liao, Dan Dion, Fabiano P. Saggioro, Felipe S. Avante, Rodolfo B. dos Reis, Jeremy A. Squire, Jane Bayani   +13 more
wiley   +1 more source

Diagnostic Value of Rapid On-Site Evaluation Combined With Prostate Biopsy in Prostate Cancer. [PDF]

Prostate
Ma H, Cao A, Hou H, Wu P, Wan B, Liu M.
europepmc   +1 more source

Castration Resistance Accelerates Prostate Cancer Kinetics

The Prostate, EarlyView.
ABSTRACT Background Prostate cancer can be an indolent disease with which patients can live for many years. Thus, an understanding of how therapy and its ensuing resistance affect prostate cancer kinetics may guide efforts to determine optimal timing of therapy initiation.
Sheila Jonnatan, Luka Cavka, Angelo M. De Marzo, Samuel R. Denmeade, Mark C. Markowski, Emmanuel S. Antonarakis, Bruce J. Trock, Catherine H. Marshall, Ravi A. Madan, David J. Einstein, Laura A. Sena   +10 more
wiley   +1 more source

Investigation of the Effectiveness of Prostate Biopsy Density in Predicting Prostate Cancer Under Cognitive and Systematic Biopsy in Multi-Parametric Magnetic Resonance Imaging (mpMRI)

Cancer Management and Research
Jiajin Feng,1,* Keming Chen,1,* Haifu Tian,1 Al-qaisi Mohammed Abdulkarem,1 Yunshang Tuo,1 Xuehao Wang,1 Bincheng Huang,1 Yu Gao,1 Zhiyong Lv,1 Rui He,2 Guangyong Li1 1General Hospital of Ningxia Medical University, Yinchuan, 750004, People’s ...
Feng J, Chen K, Tian H, Abdulkarem AQM, Tuo Y, Wang X, Huang B, Gao Y, Lv Z, He R, Li G   +10 more
doaj  

Acute hemorrhage with huge extraperitoneal hematoma following transrectal prostate biopsy: indication for emergency prostatectomy - a case report. [PDF]

J Surg Case Rep
Franz T, Stallkamp U, Lingscheidt T, Horn LC, Stolzenburg JU.   +4 more
europepmc   +1 more source

Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta‐Analysis of a Potential Therapeutic Target

The Prostate, EarlyView.
ABSTRACT Introduction The clinical relevance of HER2 expression profile in solid cancers has expanded with the evolving landscape of HER2 targeting agents. This systematic review and meta‐analysis aim to detail the prevalence of HER (over)expression in prostate cancer and identify patient/disease subgroups with enriched HER2 overexpression.
Jacky T. F. Luk, Alex H. Lin, Esther K. C. Cheung, Renald Meçani, Taulant Muka, Jana Nano, Joanna K. M. Ng, Matthew K. L. Chiu, Bryan C. W. Li, Rong Na, Joshua J. X. Li   +10 more
wiley   +1 more source